IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

Alzheimer’s prevention clinical trials ended by Novartis, Amgen and Banner

12th July 2019

Novartis, Amgen and Banner Alzheimer’s Institute has announced that they are stopping two pivotal Phase Ⅱ/Ⅲ clinical trials in the Alzheimer’s Prevention Initiative Generation Program.

The trials were developed for evaluation of the BACE1 inhibitor CNP520 (umibecestat). During the scheduled review, unblinded data was analyzed; but the results were completely opposite. The conditions of the patients got even worse in some of the measurements of cognitive function.

The trials were halted because the BACE1 inhibitor did not showed the desired results. Beta-amyloid is the protein that is responsible for Alzheimer’s disease and BACE1 inhibitor only inhibits the BACE1 enzyme that helps in amyloid plaque formation. But, it failed to significantly decrease the amyloid protein or clear it. This is the reason, why further clinical studies were halted.

Trials were conducted by the Banner Alzheimer’s Institute in collaboration with the sponsors Amgen and Novartis. Novartis leads the regulatory sponsorship.

For further enquiries, write to or call us on:
info@igmpiindia.org/ +91 8587838177, +91 8130924488, 0120-2427175, 0120-4375280

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Clinical Research Newsletter

Featured Article

GMP: A continous process

Mr Vinod Arora, Principal Advisor, IGMPI

IGMPI Placement Blog

Placement Testimonials

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like